Interviews

Marc O’Connor, chief operating officer at Curant Health, highlights upcoming trends to pay attention to within the specialty pharmacy landscape.

Sheena Babin, PharmD, business development and clinical pharmacy manager at Ochsner Health System, discusses the importance of pharmacy residency programs.

Moses Zoanna, CEO of Compliance Meds Technologies, discusses the impact of mobile health.

Cancer patient Beth Wallace provides advice to patients with leiomyosarcoma, as well as to women with cancer in general.

Beth Wallace was always one to advocate for herself in different areas of her life, but when it came to her health, she left it to the doctors. Here, she discusses the importance of education and being your own advocate.

Cancer patient Beth Wallace speaks about her support system and the impact they have made on her life.

Beth Wallace discusses various treatments for leiomyosarcoma, including doxorubicin (Adriamycin), nicknamed the red devil.

In part 2, Beth Wallace describes the events leading up to her diagnosis with leiomyosarcoma.

In part 1 of 2, Beth Wallace shares her journey leading up to her diagnosis with leiomyosarcoma.

Jon Gavras, MD, chief medical officer at Prime Therapeutics, converses about the benefits of generic drug utilization.

Ron Lanton III, Esq, president, True North Political Solutions, LLC, explains how mobile health can affect specialty pharmacies.

Joel Wright, chief executive officer, Alliance Rx Walgreens Prime discusses how technology has influenced the way specialty pharmacists manage patient care.

Jonathan Ogurchak, PharmD, CSP, vice president of Business Operations at PANTHERx Specialty Pharmacy, discusses the best strategies to ensure patient satisfaction.

Bruce A. Feinberg, DO, vice president and chief medical officer of Cardinal Health Specialty Solutions, discusses the key elements of an effective cancer clinical care pathways program.

Advice from a pharmacist for patients who are dealing with nail fungus.

Rina Shah, PharmD, Vice President, Pharmacy Operations and Specialty Pharmacy, Walgreens, talks about the importance of care coordination.

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses the importance of the treat-to target-strategy versus the non-targeted therapeutic approach in patients with rheumatoid arthritis.

Brandon Shank, PharmD, MPH, BCOP, discusses how pharmacists work with patients undergoing chemotherapy through transitions of care.

Marc O’Connor, chief operating officer at Curant Health, explains why treating the whole patient rather than just their specific disease is so important.

Sheena Babin, PharmD, business development and clinical pharmacy manager at Ochsner Health System, discusses changes specialty pharmacists will need to make to ensure adherence of self-administered specialty drugs.

Bruce A. Feinberg, DO, Vice President and Chief Medical Officer of Cardinal Health Specialty Solutions, discusses the expanding role of educational patient support programs in oncology.

Rinku Patel, PharmD, RPh, CEO and founder of KloudScript, discusses the impact of direct and indirect remuneration (DIR) fees.

Marcus H. Snow, MD, of the University of Nebraska Medical Center, discusses how education and counseling can improve the uptake of biosimilars among rheumatologists and patients.

Brandon Shank, PharmD, MPH, BCOP, discusses the role of the oncology pharmacist in providing consultation and maintaining communication with cancer patients during treatment.

Bruce A. Feinberg, DO, Vice President and Chief Medical Officer of Cardinal Health Specialty Solutions, discusses the importance of specialty pharmacists in a patient-centric environment.

Clinical pharmacists have the oppurtunity to enhance the care of patients through medication expertise.

With a shift from intravenous to self-administered medication, specialty pharmacists are key in patient education.